Common Stock	6 Months Ended
Jun. 30, 2017
Stockholders' Equity Note [Abstract]
Common Stock	9. COMMON STOCK On February 24, 2016, the Company entered into a stock repurchase agreement with two former directors, who were also members of management (the “Former Executives”) for the repurchase of all 979,114 shares owned by the Former Executives of the Company’s common stock for $1,096,608. The transaction was finalized on March 4, 2016. On June 15, 2016, the Company completed a public offering of 1,200,000 shares of its common stock and 600,000 five year warrants to purchase shares with an exercise price of $2.20 per share, at a combined public offering of $1.75 per share and half-warrant. Net proceeds to the Company from this offering were approximately $1,902,000 after deducting underwriting discounts and commissions paid by the Company. As part of the offering, there was an overallotment option for the underwriters to purchase up to 180,000 shares of common stock at a purchase price of $1.63 per share and/or up to 90,000 additional warrants at a purchase price of $0.0001 per warrant. On June 20, 2016, the underwriters exercised their right to purchase 23,320 warrants. Direct offering costs totaling approximately $124,000 were recorded as a reduction to the net proceeds on the consolidated statement of stockholders’ equity. On August 4, 2017, the Company completed a public offering of 3,625,000 shares of its common stock, offered to the public at $2.25 per share. Net proceeds to the Company from this offering were approximately $7,426,000 after deducting underwriting discounts and commissions paid by the Company. Direct offering costs are expected to approximate $200,000 which will be recorded as a reduction to the net proceeds on the consolidated statement of stockholders’ equity. The underwriters exercised their option to purchase 543,750 additional shares which resulted in additional proceeds to the Company of approximately $1,144,000.

Common Stock

6 Months Ended

Jun. 30, 2017

Stockholders' Equity Note [Abstract]

9. COMMON STOCK

On February 24, 2016, the Company entered into a stock repurchase agreement with two former directors, who were also members of management (the “Former Executives”) for the repurchase of all 979,114 shares owned by the Former Executives of the Company’s common stock for $1,096,608. The transaction was finalized on March 4, 2016.

On June 15, 2016, the Company completed a public offering of 1,200,000 shares of its common stock and 600,000 five year warrants to purchase shares with an exercise price of $2.20 per share, at a combined public offering of $1.75 per share and half-warrant. Net proceeds to the Company from this offering were approximately $1,902,000 after deducting underwriting discounts and commissions paid by the Company. As part of the offering, there was an overallotment option for the underwriters to purchase up to 180,000 shares of common stock at a purchase price of $1.63 per share and/or up to 90,000 additional warrants at a purchase price of $0.0001 per warrant. On June 20, 2016, the underwriters exercised their right to purchase 23,320 warrants. Direct offering costs totaling approximately $124,000 were recorded as a reduction to the net proceeds on the consolidated statement of stockholders’ equity.

On August 4, 2017, the Company completed a public offering of 3,625,000 shares of its common stock, offered to the public at $2.25 per share. Net proceeds to the Company from this offering were approximately $7,426,000 after deducting underwriting discounts and commissions paid by the Company. Direct offering costs are expected to approximate $200,000 which will be recorded as a reduction to the net proceeds on the consolidated statement of stockholders’ equity. The underwriters exercised their option to purchase 543,750 additional shares which resulted in additional proceeds to the Company of approximately $1,144,000.